Fresenius Medical Care AG & Co. KGaA
FMS | NYSE
$22.47
-$0.66 (-2.85%)
At close: Oct 30, 2026, 4:00 PM ET
$22.83
+$0.36 (+1.60%)
Pre-market:
Nov 2, 2026, 5:40 AM ET
Market Data
Market Cap $11.96B
Enterprise Value $19.98B
Beta 0.72
Average Volume 841.8K
Shares Outstanding (Diluted) 539.2M
Shares Change YoY -8.12%
Institutional Ownership 7.73%
Exchange NYSE
ISIN US3580291066
Price Performance
Price Change 1M 0.4%
Price Change 3M -12.4%
Price Change 6M -0.1%
Price Change YTD -5.7%
Price Change 1Y -16.3%
Price Change 3Y 35.1%
Price Change 5Y -32.4%
1M CAGR (ann.) 1.2%
1Y CAGR (ann.) -13.1%
5Y CAGR (ann.) -6.1%
All-Time CAGR -3.7%
Valuation
PE Ratio 11.60
Forward PE 8.47
PEG Ratio 0.26
Forward PEG 2.77
PS Ratio 0.53
Forward PS 0.50
PB Ratio 0.83
P/FCF Ratio 5.79
P/Adj. FCF Ratio 5.79
P/OCF Ratio 3.66
EV/Sales 1.03
EV/EBIT 10.69
EV/EBITDA 5.84
EV/FCF 11.29
Earnings Yield 8.3%
FCF Yield 16.6%
Adj. FCF Yield 16.6%
Financial Health
Net Debt €6.12B
Total Debt €10.96B
Cash & Short-Term Investments €1.45B
Total Assets €31.29B
Current Ratio 1.07
Quick Ratio 0.75
Debt / Equity Ratio 0.87
Debt / EBITDA 3.21
Debt / FCF 6.19
OCF / Debt 0.26
Interest Coverage 5.42
Altman Z-Score 1.73
Piotroski F-Score 7
Margins & Profitability
Gross Profit Margin 26.4%
Operating Profit Margin 9.7%
EBITDA Margin 18.3%
Net Profit Margin 4.8%
FCF Margin 9.1%
Adj. FCF Margin 9.1%
SBC / Revenue 0.0%
SBC Impact (per share) N/A
Returns
Return on Assets 3.0%
Return on Equity 7.2%
Return on Invested Capital 6.2%
Return on Capital Employed 8.6%
Return on Tangible Assets 5.8%
Historical Growth (CAGR)
Revenue CAGR 3Y -0.3%
Revenue CAGR 5Y 2.3%
Revenue CAGR 10Y 2.3%
EPS CAGR 3Y 42.8%
EPS CAGR 5Y 8.0%
EPS CAGR 10Y 0.1%
FCF CAGR 3Y 1.0%
FCF CAGR 5Y 3.2%
FCF CAGR 10Y 11.9%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 3
EPS Growth Next 3Y 21.5%
Revenue Growth Next 3Y 4.1%
Earnings Date Nov 3, 2026
EPS Estimate (next Q) $0.73
EPS Growth Est (next Q) 1.7%
Revenue Est (next Q) $6.22B
Revenue Growth Est (next Q) -3.2%
Fair Value Estimates
Graham Number $35.04
Graham Upside 55.9%
Lynch Fair Value $15.49
Lynch Upside -31.1%
Price Target $23.67
Price Target Upside 5.3%
Cash Flow
Operating Cash Flow €2.8B
Free Cash Flow €1.77B
Adj. Free Cash Flow €1.77B
FCF Per Share $3.32
OCF Per Share $5.27
OCF/S Ratio 14.6%
Income Statement
Revenue €19.43B
Gross Profit €5.12B
Operating Income €1.89B
EBITDA €3.42B
Net Income €937.78M
EPS (Diluted) $1.66
Revenue / Employee $179.61K
Profit / Employee $8.67K
Employees 108,165
Dividends
Annual Dividend $0.86
Dividend Yield 3.83%
Payout Ratio 52.1%
FCF Payout Ratio 0.1%
Adj. FCF Payout Ratio 0.1%
Dividend Growth (YoY) 6.1%
Pay Frequency Annual
Ex-Dividend Date May 22, 2026
Add to Watchlist
Select watchlists to add or remove FMS